Matt L.Harlow, NicholeMaloney, JosephRoland, Maria JoseGuillen Navarro, Matthew K.Easton, Susan M.Kitchen-Goosen, Elissa
A.Boguslawski, Zachary B.Madaj, Ben K.Johnson, Megan J.Bowman, MaurizioD'Incalci, Mary E.Winn, LisaTurner, GalenHostetter, Carlos MaríaGalmarini, Pablo M.Aviles and Patrick J.Grohar
Cancer ResNovember 15 2016
76
(22)
6657-6668;
DOI:10.1158/0008-5472.CAN-16-0568
This study reports the mechanism and preclinical efficacy of a
disease-specific therapy to target EWS-FLI1, the transcription factor that
drives Ewing sarcoma.
